Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma

BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma Results published in Clinical Cancer Research. Additional clinical trial in stem cell mobilization expected to commence in H1 2014.

Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma2021-06-03T06:18:05+00:00

Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment

BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment Initial results for BKT-140/BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis).

Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment2021-06-03T06:17:35+00:00

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment The phase 1 Trial of BKT-140/BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014 BKT-140/BL-8040 is also in Phase 2 for AML; top-line results expected in H2 2014 [fusion_builder_r

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment2021-06-03T06:17:04+00:00
Go to Top